DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Harmey JH, Bouchier-Hayes D.
Vascular endothelial growth factor (VEGF), a survival factor for tumour cells:
Implications for anti-angiogenic therapy.
Bioessays 2002;
24: 280-283
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.